![EGFR co-inhibition in KRAS](https://oncodaily.com/pub/uploads/2024/06/download-80-e1719418105341.jpg)
Photo of Ryan Corcoran from researchers.mgh.harvard.edu
Jun 26, 2024, 12:40
EGFR co-inhibition in KRAS
Megan Barnet, Medical Oncologist at The Kinghorn Cancer Centre, shared on X:
“Great summary from Ryan Corcoran (Mass General Cancer Center) re targeting RAS. Similar single agent ORR G12Cinh PDAC compared with NSCLC, vs CRC which improves with addition anti-EGFR. Supports KRAS good target in PDAC …just need to progress in G12D.”
Source: Megan Barnet/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023